Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Bank Oke Indonesia Tbk (DNAR) vs Brigit Biofarmaka Teknologi Tbk. (OBAT) Price & Performance

Bank Oke Indonesia TbkTrade
Brigit Biofarmaka Teknologi Tbk.Trade

Price performance (Past 24H)

Key statistics

Bank Oke Indonesia Tbk vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Bank Oke Indonesia Tbk trades at Rp121 (market cap 2.07T, 533.2K 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp242 (market cap 164.65B, 187.4K 24h volume). The key difference: Bank Oke Indonesia Tbk is far larger — about 12.6× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Bank Oke Indonesia Tbk is more actively traded (533.2K versus 187.4K). Which is the better fit depends on your goals.

DNAROBAT
Market Cap
2.07T164.65B
Volume
533.2K187.4K
Lot
5.33K1.87K
Turnover
64.79M44.35M
Average Price
121.51236.67
Value
64.79M44.35M
Indicative Equilibrium Price
121242
Indicative Equilibrium Volume
398500

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

DNAR
View details
OBAT
View details

About Bank Oke Indonesia Tbk

PT Bank Dinar Indonesia Tbk (the Bank) formerly PT Bank Liman International was established based on Notarial Deed No. 99 dated August 15, 1990 of James Herman Rahardjo, S.H.

Read more on DNAR

About Brigit Biofarmaka Teknologi Tbk.

PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.

Read more on OBAT